Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Genome Biology|January 20, 2017
Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virusXuan Liu, Emily Speranza, César Muñoz-Fontela, et al.
Msphere|September 2, 2017
Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the GutMiles W Carroll, Sam Haldenby, Natasha Y Rickett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 3, 2016
Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 DaysBoubacar Diallo, Daouda Sissoko, Nicholas J Loman, et al.
The Lancet. Global Health|December 14, 2016
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling studyDaouda Sissoko, Sophie Duraffour, Romy Kerber, et al.
The Journal of Infectious Diseases|February 22, 2019
Laboratory Findings, Compassionate Use of Favipiravir, and Outcome in Patients With Ebola Virus Disease, Guinea, 2015-A Retrospective Observational StudyRomy Kerber, Eva Lorenz, Sophie Duraffour, et al.
Plos Medicine|April 6, 2016
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in GuineaDaouda Sissoko, Cedric Laouenan, Elin Folkesson, et al.
Plos Medicine|March 2, 2016
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in GuineaDaouda Sissoko, Cedric Laouenan, Elin Folkesson, et al.
Pageof 3